ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Kaposi Study, Blocks Monitoring Plan

February 26, 1982

Symposium Planned On Hyperthermia

April 23, 1976

Komen Foundation Announces Second Grant Cycle For 1995

April 28, 1995

PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract

February 17, 1995

In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7%

January 28, 1977

Deep Budget Cuts Poised to Kick in March 1; Hill Insiders See Little Hope for Deal

February 15, 2013